BLAZE
BLAZE by Core Nutritionals is a pre-workout supplement formulated with 11 ingredients, including Acetyl-L-Carnitine HCl (1000mg) and Caffeine Anhydrous (250mg). No ingredients in this product are identified as being at clinical doses based on available research. The N+ Score for BLAZE is 66, resulting in a 'D' grade, indicating an average quality assessment. While it offers a range of ingredients commonly found in pre-workouts, the dosages may not align with research-backed clinical efficacy. This product may appeal to individuals seeking a pre-workout with various stimulant and focus components, but should be aware of the absence of clinically dosed ingredients.
About This Product
BLAZE by Core Nutritionals is a pre-workout supplement containing 11 active ingredients. It has earned an N+ Score of 66/100 (Grade D).
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +Rich formula with 11 active ingredients
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (11 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Caffeine Anhydrous | 250.000 mg | N/A |
| Theobromine | 100.000 mg | N/A |
| Acetyl L-Carnitine HCl | 1000.000 mg | N/A |
| Yohimbine HCl | 2.000 mg | N/A |
| Bacopa monnieri extract | 250.000 mg | N/A |
| GlucoVantage | 100.000 mg | N/A |
| Advantra-Z Bitter Orange extract | 75.000 mg | N/A |
| Black Cumin extract | 1000.000 mg | N/A |
| Schisandra chinensis extract | 500.000 mg | N/A |
| Caulerpa okamurae extract | 400.000 mg | N/A |
| Capsimax Capsicum annuum extract | 75.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
